The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cara Therapeutics, Inc(NASDAQ:CARA) 
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target th...
Website: http://www.caratherapeutics.com
Founded: 2004
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
Cara Therapeutics Days Payable Outstanding ttm (DPO)
Cara Therapeutics Days Receivable Outstanding ttm (DSO)
Cara Therapeutics Days Inventory Outstanding ttm (DIO)
Cara Therapeutics Op Cashflow Per Share ttm
Cara Therapeutics Free Cashflow Per Share ttm
Cara Therapeutics Cash Per Share ttm
Cara Therapeutics P/S ratio ttm
Cara Therapeutics (GAAP) P/E ratio ttm
Cara Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.